Sweden
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
18,249.32%
|
Dec. 31, 2023 | USD 8.02 | 0.46% |
|
Sweden |
|
2 |
44.88%
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
3 |
36.91%
|
Dec. 31, 2023 | USD 2.97 | 0.98% |
|
Sweden |
|
4 |
36.16%
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
5 |
34.66%
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
6 |
31.99%
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
7 |
24.64%
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
8 |
24.25%
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
9 |
18.65%
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
10 |
17.89%
|
Dec. 31, 2023 | USD 28.08 | 0.23% |
|
Sweden |
|
11 |
16.27%
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
12 |
15.82%
|
Dec. 31, 2023 | USD 42.37 | 0.78% |
|
Sweden |
|
13 |
14.00%
|
Dec. 31, 2023 | USD 52.21 | -0.68% |
|
Sweden |
|
14 |
13.35%
|
Dec. 31, 2023 | USD 28.64 | 0.87% |
|
Sweden |
|
15 |
11.97%
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
16 |
10.88%
|
Dec. 31, 2023 | USD 14.61 | 2.17% |
|
Sweden |
|
17 |
10.77%
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
18 |
10.71%
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
19 |
10.50%
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
20 |
10.34%
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
21 |
9.21%
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
22 |
8.85%
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
23 |
8.69%
|
Dec. 31, 2023 | USD 26.00 | 1.16% |
|
Sweden |
|
24 |
6.45%
|
Dec. 31, 2023 | USD 4.73 | 3.81% |
|
Sweden |
|
25 |
5.86%
|
Dec. 31, 2023 | USD 3.41 | 3.24% |
|
Sweden |
|
26 |
5.83%
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
27 |
5.80%
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
28 |
5.27%
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
29 |
3.50%
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
30 |
3.47%
|
Dec. 31, 2023 | USD 3.87 | 2.52% |
|
Sweden |
|
31 |
2.77%
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
32 |
2.66%
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
33 |
1.92%
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
34 |
1.35%
|
Dec. 31, 2023 | USD 17.18 | 2.59% |
|
Sweden |
|
35 |
1.20%
|
Dec. 31, 2023 | USD 0.12 | 3.82% |
|
Sweden |
|
36 |
0.73%
|
Dec. 31, 2023 | USD 0.23 | -0.87% |
|
Sweden |
|
37 |
-0.00%
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
38 |
-0.87%
|
Dec. 31, 2023 | USD 0.14 | 1.34% |
|
Sweden |
|
39 |
-1.11%
|
Dec. 31, 2023 | USD 1.35 | -1.92% |
|
Sweden |
|
40 |
-3.96%
|
Dec. 31, 2023 | USD 0.78 | 5.47% |
|
Sweden |
|
41 |
-4.60%
|
Dec. 31, 2023 | USD 0.28 | 6.05% |
|
Sweden |
|
42 |
-7.23%
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
43 |
-11.89%
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
44 |
-21.09%
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
45 |
-21.63%
|
Dec. 31, 2023 | USD 0.15 | 3.82% |
|
Sweden |
|
46 |
-21.96%
|
Dec. 31, 2023 | USD 1.76 | 2.86% |
|
Sweden |
|
47 |
-24.24%
|
April 30, 2024 | USD 0.14 | 0.68% |
|
Sweden |
|
48 |
-32.13%
|
Dec. 31, 2023 | USD 10.16 | -0.20% |
|
Sweden |
|
49 |
-38.36%
|
Dec. 31, 2023 | USD 1.42 | 3.80% |
|
Sweden |
|
50 |
-41.84%
|
Aug. 31, 2024 | USD 0.30 | -1.39% |
|
Sweden |
The Pharmaceuticals company in Sweden with the highest EBT Margin is Linc AB (Stockholm Stock Exchange: LINC.ST) at 18,249.32%.
The Pharmaceuticals company in Sweden with the lowest EBT Margin is OncoZenge AB (publ) (Stockholm Stock Exchange: ONCOZ.ST) at -530,066.67%.
The top 10 Pharmaceuticals companies in Sweden by EBT Margin are Linc AB, BioArctic AB (publ), Intellego Technologies AB, BioGaia AB (publ), Genovis AB (publ.), Camurus AB (publ), Sleep Cycle AB (publ), CellaVision AB (publ), Sectra AB (publ) and Lifco AB (publ).
The bottom 10 Pharmaceuticals companies in Sweden by EBT Margin are OncoZenge AB (publ), Infant Bacterial Therapeutics AB (publ), Diamyd Medical AB (publ), Lipum AB (publ), Qlife Holding AB (publ), SpectraCure AB (publ), Kancera AB (publ), Alzinova AB (publ), Nanologica AB (publ) and Isofol Medical AB (publ).